Aberrant mitochondrial DNA synthesis in macrophages exacerbates inflammation and atherosclerosis

Niranjana Natarajan1, Jonathan Florentin1, Ebin Johny1

  • 1Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute, Division of Cardiology, Department of Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.

Nature Communications
|August 26, 2024
PubMed

Insights

Vascular cell adhesion molecule 1 (VCAM-1) drives mitochondrial DNA synthesis in macrophages, worsening atherosclerosis. Inhibiting VCAM-1 in macrophages reduces inflammation and disease severity, revealing a key pathway in cardiovascular disease progression.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cellular Metabolism

Background:

  • Cellular metabolism significantly influences inflammation and atherosclerosis progression.
  • The specific role of mitochondrial DNA (mtDNA) synthesis in macrophage function and atherosclerosis remains unclear.

Purpose of the Study:

  • To investigate the link between mitochondrial DNA synthesis, macrophage function, and atherosclerosis pathology.
  • To elucidate the molecular mechanisms by which mitochondrial DNA synthesis is regulated in atherosclerotic macrophages.

Main Methods:

  • Transcriptomic analysis of plaque macrophages and spatial single-cell transcriptomics of atherosclerotic plaques.
  • Functional experiments in human and mouse models, including Apoe-/- mice lacking Vcam1 in macrophages.
  • Assessment of VCAM-1 expression correlation with plaque characteristics and oxidative damage in human carotid plaques.

Main Results:

  • Vascular cell adhesion molecule 1 (VCAM-1) triggers mitochondrial DNA (mtDNA) synthesis in atherosclerotic plaque macrophages under inflammatory conditions.
  • VCAM-1 activates C/EBPα, leading to increased expression of Cmpk2 and Pgc1a, promoting mtDNA synthesis and STING-mediated inflammation.
  • Mice lacking VCAM-1 in macrophages exhibit reduced atherosclerosis and inflammation; VCAM-1 expression correlates with plaque severity and DNA damage in humans.

Conclusions:

  • Macrophage VCAM-1 plays a critical role in promoting inflammation and atherogenesis through a VCAM-1-C/EBPα-mtDNA synthesis-STING pathway.
  • This pathway represents a self-acerbating mechanism contributing to cardiovascular disease.
  • Targeting macrophage VCAM-1 may offer a therapeutic strategy for atherosclerosis.